Filgrastim XM02 (Tevagrastim®) after autologous stem cell transplantation compared to lenograstim: favourable cost-efficacy analysis

por Gardellini, A, Gigli, F, Babic, A, Andreola, G, Radice, D, Sammassimo, S, Martinelli, G, Laszlo, D
Publicado 2013